These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2670348)

  • 21. Heterogeneity of sialoglycoproteins purified from normal and malignant cells.
    Litin BS; Grimes WJ
    Cancer Res; 1983 May; 43(5):2131-7. PubMed ID: 6831439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist.
    Liu J; Zhao ML; Brosnan CF; Lee SC
    J Immunol; 1996 Oct; 157(8):3569-76. PubMed ID: 8871657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta.
    Lundqvist EN; Companjen AR; Prens EP; Egelrud T
    Eur Cytokine Netw; 1998 Mar; 9(1):41-6. PubMed ID: 9613676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
    Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human interleukin 1. Purification to homogeneity.
    Kronheim SR; March CJ; Erb SK; Conlon PJ; Mochizuki DY; Hopp TP
    J Exp Med; 1985 Mar; 161(3):490-502. PubMed ID: 3871836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies.
    Ogata K; Ogata Y; Nakamura RM; Tan EM
    J Immunol; 1985 Oct; 135(4):2623-7. PubMed ID: 2863307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH; Robbins PD
    Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of a unique human interleukin 1 from the tumor cell line U937.
    Knudsen PJ; Dinarello CA; Strom TB
    J Immunol; 1986 May; 136(9):3311-6. PubMed ID: 3485687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cell proliferation by interleukin-1 derived from monocytic leukemia cells.
    Tsai SC; Gaffney EV
    Cancer Res; 1986 Mar; 46(3):1471-7. PubMed ID: 3484681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The M20 IL-1 inhibitor. I. Purification by preparative isoelectric focusing in free solution.
    Peritt D; Flechner I; Okunev E; Yanai P; Halperin T; Treves AJ; Barak V
    J Immunol Methods; 1992 Nov; 155(2):159-65. PubMed ID: 1431146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of a bovine cerebral cortex cell surface sialoglycopeptide that inhibits cell proliferation and metabolism.
    Sharifi BG; Johnson TC; Khurana VK; Bascom CC; Fleenor TJ; Chou HH
    J Neurochem; 1986 Feb; 46(2):461-9. PubMed ID: 2416876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further characterization of a melanoma-specific protein from human urine.
    Bennett C; Cooke KB
    Br J Cancer; 1980 May; 41(5):734-44. PubMed ID: 6158965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human urine deoxyribonuclease increases endogenous thymidine in the mouse thymocyte interleukin 1 assay: an artificial interleukin-1 inhibitor.
    Svenson M; Bendtzen K
    Cytokine; 1989 Nov; 1(1):52-5. PubMed ID: 2491505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation of sialoglycoprotein fractions having influenza virus-receptor activity from human meconium and some of their chemical properties.
    Ohyama K; Shinozuka T; Yanagida J; Yamakawa T
    Biol Pharm Bull; 1997 Nov; 20(11):1141-6. PubMed ID: 9401720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and properties of gamma protein, the major transmembrane sialoglycoprotein of the HeLa cell.
    Kramer RH; Canellakis ES
    J Supramol Struct; 1979; 12(4):435-55. PubMed ID: 550009
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation and characteristics of human urinary sialoglycoproteins.
    Berggård I; Ekström B; Lisowska E; Lundblad A
    Eur J Biochem; 1981 Mar; 115(1):183-8. PubMed ID: 7227365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.